API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com/news-release/2022/09/27/2523270/0/en/BetterLife-Files-Comprehensive-Patent-for-BETR-001-and-Other-LSD-Derivatives.html
https://www.prnewswire.com/news-releases/mindmed-announces-publication-of-study-comparing-the-acute-effects-of-lysergic-acid-diethylamide-and-psilocybin-in-healthy-subjects-301493703.html
https://www.globenewswire.com/news-release/2022/02/15/2385232/0/en/BetterLife-Lead-Drug-BETR-001-Promotes-Structural-Neural-Plasticity-in-Preclinical-Model.html
https://www.pharmacompass.com/pdf/news/betterlife-receives-fda-response-on-its-pre-ind-application-for-major-depressive-disorder-mdd-treatment-with-betr-001-1643725774.pdf
https://www.prnewswire.com/news-releases/mindmed-initiates-phase-2a-lsd-trial-for-the-treatment-of-adult-adhd-301447252.html
https://www.pharmacompass.com/pdf/news/betterlife-enters-research-agreement-with-medical-college-wisconsin-for-td-0148a-1632399362.pdf
https://www.globenewswire.com/news-release/2021/06/14/2246436/0/en/Mindset-and-InterVivo-Solutions-Announce-Availability-of-First-Preclinical-Psychedelic-Benchmark-Data-from-COPE-Program.html